Relief Therapeutics - eine COVID-19 Hoffnung? (Seite 470)
eröffnet am 11.03.20 17:46:44 von
neuester Beitrag 10.05.24 10:12:00 von
neuester Beitrag 10.05.24 10:12:00 von
Beiträge: 14.085
ID: 1.321.697
ID: 1.321.697
Aufrufe heute: 34
Gesamt: 2.518.801
Gesamt: 2.518.801
Aktive User: 0
ISIN: CH1251125998 · WKN: A3EFB5 · Symbol: RLF
1,2800
CHF
+1,59 %
+0,0200 CHF
Letzter Kurs 17:04:31 SIX Swiss (CHF)
Neuigkeiten
Werte aus der Branche Biotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,9600 | +40,00 | |
| 3,9600 | +28,57 | |
| 3,6300 | +27,82 | |
| 3,7300 | +25,59 | |
| 0,6230 | +23,86 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,5350 | -20,15 | |
| 0,7601 | -23,98 | |
| 2,0000 | -30,07 | |
| 2,8350 | -31,19 | |
| 0,6162 | -56,61 |
Beitrag zu dieser Diskussion schreiben
FeedbackNaher Osten
was hört man denn von der Vergabe von Aviptadil im Kaukasus und in Indien, was beider groß angekündigt war?
Antwort auf Beitrag Nr.: 68.706.119 von Hamburger123 am 07.07.21 00:20:28Ohne News hängt die Aktie im Wind
Irgendwie beschleicht mich das Gefühl, dass es hier nur noch eine Rtg. geben wird. Leider weiter runter!
NRx Pharmaceuticals Announces Initiation of Emergency Use Training and Extension of Phase 2/3 Inhaled ZYESAMI™ (Aviptadil-acetate) Trial in the Nation of Georgia :: NRx Pharmaceuticals, Inc. (NRXP)
https://ir.nrxpharma.com/news-events/press-releases/detail/7…
https://ir.nrxpharma.com/news-events/press-releases/detail/7…
There is another point to be mentioned:
Obviously, if the products of Relief are being officially introduced in the COVID19 circuit the
producers of Vaccine will be faced with a strong competition and this is certainly a foremost
worry in their heads!
The only way to avoid this is to stop recognicion by the FDA and keep the shares at an
unattractive level to discourage people from considering these two medicines as an alternative.
Interesting: both medicaments are apparently selling freely and very well in South Africa!!
Regards
Corradini
Obviously, if the products of Relief are being officially introduced in the COVID19 circuit the
producers of Vaccine will be faced with a strong competition and this is certainly a foremost
worry in their heads!
The only way to avoid this is to stop recognicion by the FDA and keep the shares at an
unattractive level to discourage people from considering these two medicines as an alternative.
Interesting: both medicaments are apparently selling freely and very well in South Africa!!
Regards
Corradini
Trading Spotlight
Aus YF
mark3 minutes ago
https://epaper.nzz.ch/article/6/6/2021-07-06/25/285575442?si…
Relief is mentioned
mark3 minutes ago
https://epaper.nzz.ch/article/6/6/2021-07-06/25/285575442?si…
Relief is mentioned
Antwort auf Beitrag Nr.: 68.692.118 von Alpsee1 am 05.07.21 17:00:40Dem kann ich nur zustimmen!!!
Möchte weder Pusher noch Basher sein, aber halte das für einen interessanten Beitrag aus dem Yahoo-Forum
MOld) James1 minute ago
Maybe that older French virologist was not totally wrong six weeks ago or whenever he appeared on Utube. For one of the known experts in the field, he sounded radical when he said multiple vaccines were a big mistake, that they will only spawn more mutations as the virus evolves to survive.
The old boy sounded over the edge, but consider the sheer number of covid variants which now exist, and how quickly they evolved. The government bet the first year on antibodies, via fast vaccines and MAB treatments, and their initial success is breaking down exactly as the Virologist said.
We need a different toolkit going into the next cold and flu season. Aviptadil and Zyesami will be a big part of that new toolkit, and it will NOT be limited to the most severe patients. This natural remedy gathers more data and looks better every day in multiple ongoing trials. The only people who could need this much time see the obvious are .......federal bureaucrats.
MOld) James1 minute ago
Maybe that older French virologist was not totally wrong six weeks ago or whenever he appeared on Utube. For one of the known experts in the field, he sounded radical when he said multiple vaccines were a big mistake, that they will only spawn more mutations as the virus evolves to survive.
The old boy sounded over the edge, but consider the sheer number of covid variants which now exist, and how quickly they evolved. The government bet the first year on antibodies, via fast vaccines and MAB treatments, and their initial success is breaking down exactly as the Virologist said.
We need a different toolkit going into the next cold and flu season. Aviptadil and Zyesami will be a big part of that new toolkit, and it will NOT be limited to the most severe patients. This natural remedy gathers more data and looks better every day in multiple ongoing trials. The only people who could need this much time see the obvious are .......federal bureaucrats.
Relief zulassung
Es wurde ja mitgeteilt dass die Zulassung bei der FDA eingereicht wurde, mal schauen wie lange dass noch geht, zudem hat man noch weitere positive Nebenwirkungen festgestellt die weiteren Abklärung bedürfen. Bin gespannt wie sich der Laden entwickelt, heute wird nichts gehen die Amis haben frei und alles andere kommt irgendwann................
Hat Relief eigentlich vor einen Antrag bei der EMA einzureichen oder warten die auf die FDA?
Durchsuchen
Relief Therapeutics - eine COVID-19 Hoffnung?
